<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00889486</url>
  </required_header>
  <id_info>
    <org_study_id>TZP-102-CL-G002</org_study_id>
    <nct_id>NCT00889486</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus</brief_title>
  <official_title>A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Evaluation of the Safety and Efficacy of Once-Daily Administrations of TZP 102 for the Treatment of Symptomatic Gastroparesis in Patients With Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tranzyme, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tranzyme, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of TZP-102 on gastric emptying rate,
      gastroparesis symptoms and health-related quality of life in diabetic patients with
      gastroparesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in gastric half-emptying time</measure>
    <time_frame>study days 1 and 28</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline in gastroparesis symptoms and health-related quality of life</measure>
    <time_frame>study days 8, 15 and 28</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Gastroparesis</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Four placebo capsules taken orally once per day for 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 mg TZP-102</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One 10 mg TZP-102 Capsule and three placebo capsules taken orally once per day for 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 mg TZP-102</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two 10 mg TZP-102 Capsules and two placebo capsules taken orally once per day for 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40 mg TZP-102</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four 10 mg TZP-102 Capsules taken orally once per day for 28 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TZP-102</intervention_name>
    <arm_group_label>10 mg TZP-102</arm_group_label>
    <arm_group_label>20 mg TZP-102</arm_group_label>
    <arm_group_label>40 mg TZP-102</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>10 mg TZP-102</arm_group_label>
    <arm_group_label>20 mg TZP-102</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 80 years of age, inclusive.

          -  Type 1 or type 2 diabetes mellitus.

          -  Female patients of childbearing potential must have a negative serum pregnancy test
             and use (and agree to continue to use throughout the study) an acceptable method of
             contraception.

          -  HbA1c level less than/equal to 10.0 % at the Screening Visit.

          -  Diagnosis of gastroparesis including (all three of the following requirements apply):
             i. Documented delayed gastric emptying; ii. A greater than 3 month history of symptoms
             of gastroparesis; iii. A GCSI Total Score greater than/equal to 2.66 at the Screening
             Visit and greater than/equal to 1.90 at the Day 1 visit.

          -  Upper gastrointestinal obstruction ruled out by endoscopy or barium scan.

          -  Concomitant medications must be stable for at least 2 weeks leading up to the Baseline
             Visit and be maintained during the study.

          -  Body Mass Index (BMI) &lt; 35.

          -  Delayed gastric emptying by breath test demonstrated at the Baseline Visit.

        Exclusion Criteria:

          -  Persistent daily vomiting

          -  Gastrectomy, obesity surgery, fundoplication, or vagotomy/pyloroplasty.

          -  Pyloric Botox within 6 months prior to Screening Visit.

          -  NG, PEG or PEJ feeding tube.

          -  Required in-patient hospitalization for treatment of gastroparesis within 2 weeks
             prior to the Screening Visit.

          -  Parenteral nutrition for treatment of gastroparesis within 2 months prior to the
             Screening Visit.

          -  Active gastric pacemaker within 3 months prior to the Screening Visit.

          -  Participation in an investigational study within 30 days prior to study entry.

          -  Chronic severe diarrhea.

          -  Diabetic ketoacidosis requiring hospitalization within 30 days prior to study entry.

          -  History of any eating disorder within 2 years prior to study entry.

          -  Significant chronic obstructive pulmonary disease or chronic asthma.

          -  Patient is a heavy smoker, and/or unable or unwilling to abstain from smoking during
             each of the three study visits during which the gastric emptying breath tests will be
             performed.

          -  History of risk factors for Torsades de Pointes.

          -  Patient requires treatment with certain concomitant medications known to have a
             clinically recognized risk for Torsades de Pointes.

          -  History of acute myocardial infarction (MI) or unstable angina within 12 months prior
             to study entry.

          -  History of any psychiatric disorder or cognitive impairment that would interfere with
             participation in the study.

          -  History of alcohol dependency within 2 years prior to study entry.

          -  Taking opiates for abdominal pain.

          -  History of HIV infection.

          -  History of Hepatitis B or C currently exhibiting symptoms expected to worsen during
             course of study.

          -  Requires dialysis or has severely impaired renal function.

          -  Severe impairment of liver function.

          -  Uncontrolled hypo- or hyperthyroidism.

          -  History of adrenal insufficiency.

          -  Pregnant or is breast-feeding.

          -  Allergic to or intolerant of wheat, egg, soy or milk products.

          -  Patient requires a gluten-free diet.

          -  Any other medical condition or social circumstance that, in the investigator's
             opinion, makes it inappropriate for the patient to participate in this clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Long Beach VA Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Impact Clinical Trials</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center Research Institute</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida/Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Research Institute</name>
      <address>
        <city>Anderson</city>
        <state>Indiana</state>
        <zip>46012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. of Louisville Medical-Dental Complex</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech Univ. Health Sciences Center Dept. of Medicine</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aalborg Hospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Steno Diabetes Center</name>
      <address>
        <city>Gentofte</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny w Bialymstoku</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Kliniczny Diabetologii Samodzielny Publiczny Zaklad</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ipswich Hospital NHS Trust</name>
      <address>
        <city>Ipswich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellcome Truest Clinical Research Facility</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2009</study_first_submitted>
  <study_first_submitted_qc>April 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2009</study_first_posted>
  <disposition_first_submitted>December 5, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>December 5, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">December 7, 2012</disposition_first_posted>
  <last_update_submitted>December 7, 2012</last_update_submitted>
  <last_update_submitted_qc>December 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gastroparesis</keyword>
  <keyword>diabetes mellitus</keyword>
  <keyword>delayed gastric emptying</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

